The Monoterpenoid Perillyl Alcohol: Anticancer Agent and Medium to Overcome Biological Barriers.

Chen, Thomas C; da Fonseca, Clovis O; Levin, Daniel; Schönthal, Axel H

Chen, Thomas C; da Fonseca, Clovis O; Levin, Daniel; Schönthal, Axel H.

Afiliação

Chen TC; Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.
da Fonseca CO; Department of Neurological Surgery, Federal Hospital of Ipanema, Rio de Janeiro 22411-020, Brazil.
Levin D; Norac Pharma, Azusa, CA 91702, USA.
Schönthal AH; Department of Molecular Microbiology & Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.

Pharmaceutics ; 13(12)2021 Dec 16.

Article em En | MEDLINE | ID: mdl-34959448

Palavras-chave

NEO100; bloodbrain barrier; drug formulation; drug hybrids; intra-arterial delivery; intracranial malignancies; intranasal delivery; monoterpene; monoterpenoid

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google